Director/PDMR Shareholding

RNS Number : 6485B

GlaxoSmithKline PLC

14 February 2022

 

GlaxoSmithKline plc   (the ' Company ')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms S Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financialinstrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The sale of 1,226 Ordinary Shares to facilitate a transfer into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.3267 1,226
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-02-10
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms S Jackson
b)	Position/status	SVP, Global Communications & CEO Office
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financialinstrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The purchase of 1,218 Ordinary Shares into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.3210 1,218
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-02-10
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D Jackson
b)	Position/status	PCA of Ms S Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financialinstrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The sale of 1,226 Ordinary Shares to facilitate a transfer into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £ 16.3287 1,226
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-02-10
f)	Placeofthe transaction	London Stock Exchange ( XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr D Jackson
b)	Position/status	PCA of Ms S Jackson (SVP, Global Communications & CEO Office)
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Descriptionofthe financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature ofthe transaction	The purchase of 1,219 Ordinary Shares into an ISA.
c)	Price(s)and volume(s)	Price(s) Volume(s) £16.3133 1,219
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date ofthe transaction	2022-02-10
f)	Placeofthe transaction	London Stock Exchange ( XLON)

 

END

 

 

DSHDZLFFLLLZBBK